Back to search

Article

How Can New TB Vaccines Be Effectively Introduced in Indonesia? Insights from Diverse Stakeholders

2025-11-13

Abstract excerpt

<h4>Background</h4> New adult tuberculosis (TB) vaccines are in clinical trials and may be licensed as soon as 2028. However, vaccine rollout requires addressing multiple contextual factors beyond clinical trial findings. This study explored stakeholders’ perspectives on the introduction a new TB vaccine in Indonesia. <h4>Methods</h4> We used a mixed-methods approach combining a stakeholder consultation in Jakar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
42d5a57c-2a2b-5a45-ad66-9986d01bcf95
DOI
10.1101/2025.11.11.25340047
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
How Can New TB Vaccines Be Effectively Introduced in Indonesia? Insights from Diverse StakeholdersDOI 10.1101/2025.11.11.25340047
Prevalence and individual level enablers and barriers for COVID-19 vaccine uptake among adult tuberculosis patients attending selected clinics in Nairobi County, KenyaSemantic proximity
Melioidosis Vaccines (MeVa): Attitudes to vaccines, melioidosis and clinical trials in key stakeholders in Ubon Ratchathani, ThailandSemantic proximity
Programmatic considerations for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysisSemantic proximity
Advancing Vaccine Access in Tanzania through Community Drug Outlets: A Pre-Implementation Survey on the Acceptability, Appropriateness, and FeasibilitySemantic proximity
The TB vaccine clinical trial centre directory: an inventory of clinical trial centres in sub-Saharan AfricaSemantic proximity
A Systematic Review on Malaria and Tuberculosis (TB) Vaccine Challenges in Sub-Saharan African Clinical TrialsSemantic proximity
TB vaccines: global solutions for global problems.Semantic proximity
Facilitators and barriers influencing willingness to take the malaria vaccine among mothers of under 5 years in Abuja, NigeriaSemantic proximity
Stakeholders’ Perspectives on Rationing COVID-19 Vaccines Amidst Extreme Scarcity: A Qualitative StudySemantic proximity
End-user perspectives on the acceptability, feasibility, and health equity impacts of Mycobacterium tuberculosis specific antigen-based skin tests compared to interferon gamma release assays and the tuberculin skin test: A semi-structured interview studySemantic proximity
Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysisSemantic proximity
Critical interventions for demand generation in Zambia, Nepal, and Senegal with regards to the 5C psychological antecedents of vaccinationSemantic proximity
Select a neighboring publication to make it the new centre.